Global Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Forecast 2024-2030- Product Image

Sale

Global Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Forecast 2024-2030

Report
184 Pages
March 2024
Region: Global
360iResearch™
ID: 4857893

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Regenerative Medicine Market size was estimated at USD 24.01 billion in 2023, USD 28.82 billion in 2024, and is expected to grow at a CAGR of 20.13% to reach USD 86.73 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Regenerative Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Regenerative Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Regenerative Medicine Market, highlighting leading vendors and their innovative profiles. These include Allergan PLC, Amgen Inc., Bayer AG, Gilead Sciences, Inc., Integra LifeSciences Holdings Corporation, Medtronic PLC, Mimedx Group, Novartis AG, Organogenesis Inc., Osiris Therapeutics, Inc. by Smith & Nephew PLC, Stryker Corporation, Takeda Pharmaceutical Co. Ltd., Vericel Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings Inc.

Market Segmentation & Coverage

This research report categorizes the Regenerative Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Cell-Based Immunotherapy & Cell Therapy Products
  - Allogeneic Products
  - Autologous Products
- Gene Therapy Products
- Small Molecule & Biologic
- Tissue-Engineered Products
Application
- Cardiovascular
- Diabetes
- Musculoskeletal Disorders
- Ocular Disorders
- Oncology
- Wound Care

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Regenerative Medicine Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Regenerative Medicine Market?
What are the technology trends and regulatory frameworks in the Regenerative Medicine Market?
What is the market share of the leading vendors in the Regenerative Medicine Market?
Which modes and strategic moves are suitable for entering the Regenerative Medicine Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Regenerative Medicine Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing adoption of stem cell technologies, gene therapies, and tissue engineering
5.1.1.2. Technological advancements in regenerative medicine biologics, 3D bioprinting, and biomaterials
5.1.1.3. Product approval coupled with rising government investments in regenerative medicine research
5.1.2. Restraints
5.1.2.1. Ethical issues related to the use of embryonic stem cells in R&D
5.1.3. Opportunities
5.1.3.1. Growing demand for organ transplantation and bone grafting
5.1.3.2. Increasing R&D activities by private players coupled with the involvement of academic institutes for research
5.1.4. Challenges
5.1.4.1. Regulatory issues pertaining to stem cell, tissues engineering and regenerative medicine
5.1.4.2. High cost associated with treatment
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Regenerative Medicine Market, by Type

6.1. Introduction
6.2. Cell-Based Immunotherapy & Cell Therapy Products
6.3.1. Allogeneic Products
6.3.2. Autologous Products
6.3. Gene Therapy Products
6.4. Small Molecule & Biologic
6.5. Tissue-Engineered Products

7. Regenerative Medicine Market, by Application

7.1. Introduction
7.2. Cardiovascular
7.3. Diabetes
7.4. Musculoskeletal Disorders
7.5. Ocular Disorders
7.6. Oncology
7.7. Wound Care

8. Americas Regenerative Medicine Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Regenerative Medicine Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Regenerative Medicine Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
12.1.1. Allergan PLC
12.1.2. Amgen Inc.
12.1.3. Bayer AG
12.1.4. Gilead Sciences, Inc.
12.1.5. Integra LifeSciences Holdings Corporation
12.1.6. Medtronic PLC
12.1.7. Mimedx Group
12.1.8. Novartis AG
12.1.9. Organogenesis Inc.
12.1.10. Osiris Therapeutics, Inc. by Smith & Nephew PLC
12.1.11. Stryker Corporation
12.1.12. Takeda Pharmaceutical Co. Ltd.
12.1.13. Vericel Corporation
12.1.14. Wright Medical Group N.V.
12.1.15. Zimmer Biomet Holdings Inc.
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. REGENERATIVE MEDICINE MARKET RESEARCH PROCESS
FIGURE 2. REGENERATIVE MEDICINE MARKET SIZE, 2023 VS 2030
FIGURE 3. REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. REGENERATIVE MEDICINE MARKET DYNAMICS
FIGURE 7. REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. REGENERATIVE MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 8. REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE & BIOLOGIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 32. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 35. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 49. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 52. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 58. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 76. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 86. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 89. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 92. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 95. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 98. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 104. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 113. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 116. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 119. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 131. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 140. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 148. REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 149. REGENERATIVE MEDICINE MARKET LICENSE & PRICING

Companies Mentioned

Allergan PLC
Amgen Inc.
Bayer AG
Gilead Sciences, Inc.
Integra LifeSciences Holdings Corporation
Medtronic PLC
Mimedx Group
Novartis AG
Organogenesis Inc.
Osiris Therapeutics, Inc. by Smith & Nephew PLC
Stryker Corporation
Takeda Pharmaceutical Co. Ltd.
Vericel Corporation
Wright Medical Group N.V.
Zimmer Biomet Holdings Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	184
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 28.82 Billion
Forecasted Market Value ( USD ) by 2030	$ 86.73 Billion
Compound Annual Growth Rate	20.1%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,804GBP €3624EUR$3,749USD£3,115GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,551GBP €4591EUR$4,749USD£3,946GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,299GBP €5558EUR$5,749USD£4,777GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,047GBP €6524EUR$6,749USD£5,608GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7612EUR$7,874USD£6,543GBP €8458EUR$8,749USD£7,270GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Regenerative Medicine Market Size, Share & Trends Analysis Report by Product (Primary Cell-based Therapeutics, Stem Cell & Progenitor Cell-based Therapeutics), Therapeutic Category (Dermatology, Musculoskeletal), Region, and Segment Forecasts, 2024-2030

Regenerative Medicine Market: Trends, Forecast and Competitive Analysis

Global Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application (Musculoskeletal, Cancer, Dermatology, Wound care, Cardiovascular Diseases, Eye Disorders) - Forecast to 2028

Global Translational Regenerative Medicine Market by Product Type (Cell Based Product, Gene Therapy Product, Tissue Engineered Product), Application (Cardiovascular, Dermatology, Diabetes) - Forecast 2024-2030

Global Artificial Intelligence in Regenerative Medicine Market by Technology (Computer Vision, Context-Aware Computing, Machine Learning), Offering (Hardware, Services, Software), Application, End-User - Forecast 2024-2030